On the night of his 12th wedding anniversary, Andrew Friedman was terrified.
This brilliant surgeon and researcher at Brigham and Women's Hospital and Harvard Medical School feared that he was about to lose everything -- his career, his family, the life he'd built -- because his boss was coming closer and closer to the truth: For the past three years, Friedman had been faking -- actually making up -- data in some of the respected, peer-reviewed studies he had published in top medical journals.
``It is difficult for me to describe the degree of panic and irrational thought that I was going through,'' he would later tell an inquiry panel at Harvard.
On this night, March 13, 1995, he had been ordered in writing by his department chair to clear up what appeared to be suspicious data.
But Friedman didn't clear things up.
``I did something which was the worst possible thing I could have done,'' he testified.
He went to the medical record room, and for the next three or four hours he pulled out the permanent medical files of a handful of patients. Then he covered up his lies, scribbling in the information he needed to support his study.
``I created data. I made it up. I also made up patients that were fictitious,'' he testified.
Friedman's wife met him at the door when he came home that night. He wept uncontrollably. The next morning he had an emergency appointment with his psychiatrist.
But he didn't tell the therapist the truth, and his lies continued for 10 more days, during which time he delivered a letter, and copies of the doctored files, to his boss. Eventually he broke down, admitting first to his wife and psychiatrist, and later to his colleagues and managers, what he had been doing.
Friedman formally confessed, retracted his articles, apologized to colleagues and was punished. Today he has resurrected his career, as senior director of clinical research at Ortho-McNeil Pharmaceutical Inc, a Johnson & Johnson company.
His case, recorded in a 2.1m-high stack of documents at the Massachusetts Board of Registration in Medicine, tells a story of one man's struggle with power, lies and the crushing pressure of academia.
The story itself is more common than most people might realize.
Allegations of research misconduct reached record highs in the United States last year -- the Department of Health and Human Services received 274 complaints, which was 50 percent higher than 2003 and the most since 1989, when the federal government established the program to deal with scientific misconduct.
Chris Pascal, director of the federal Office of Research Integrity, said its 28 staffers and US$7 million annual budget haven't kept pace with the allegations. The result: Only 23 cases were closed last year. Of those, eight individuals were found guilty of research misconduct. In the past 15 years, the office has confirmed about 185 cases of scientific misconduct.
Research suggests this is but a small fraction of all the incidents of fabrication, falsification and plagiarism. In a survey published June 9 in the journal Nature, about 1.5 percent of 3,247 researchers who responded admitted to falsification or plagiarism. One in three admitted to some type of professional misbehavior.
Some cases have made headlines:
Eric Poehlman was convicted this year of fabricating research data to obtain a US$542,000 federal grant while working as a professor at the University of Vermont College of Medicine.
Also this year, Gary Kammer, a Wake Forest University rheumatology professor and leading lupus expert, was found to have made up two families and their medical conditions in grant applications to the National Institutes of Health. He has resigned from the university and has been suspended from receiving federal grants for three years.
In November, 2004, federal officials found that Ali Sultan, an award-winning malaria researcher at the Harvard School of Public Health, had plagiarized text and figures, and falsified his data -- substituting results from one type of malaria for another -- on a grant application for federal funds to study malaria drugs.
While recent cases have been high-profile, they are not unprecedented.
In 1974, William Summerlin, a top-ranking Sloan-Kettering Cancer Institute researcher, used a marker to make black patches of fur on white mice in an attempt to prove his new skin graft technique was working.
His case prompted Al Gore, then a young Democratic congressman, to hold the first congressional hearings on the issue.
``At the base of our involvement in research lies the trust of American people and the integrity of the scientific exercise,'' said Gore at the time. As a result of the hearings, Congress passed a law in 1985 requiring institutions that receive federal money for scientific research to have some system to report rulebreakers.
David Wright, a Michigan State University professor who has researched why scientists cheat, said there are four basic reasons: some sort of mental disorder; foreign nationals who learned somewhat different scientific standards; inadequate mentoring; and, most commonly, tremendous and increasing professional pressure to publish studies.
His inability to handle that pressure, Friedman testified, was his downfall. At the time he started cheating, Friedman's reputation was tremendous and his work groundbreaking.
``And it was almost as though you're on a treadmill that starts out slowly and gradually increases in speed. And it happens so gradually you don't realize that eventually you're just hoping you don't fall off,'' he told a magistrate during a state hearing in 1995. ``You're sprinting near the end and taking it all you can not to fall off.''
He testified that he was working 80 to 90 hours a week, with patient visits, surgery, meetings and more. He did seek help, both from a psychiatrist, who counseled him to cut back, and from his boss, who demanded Friedman increase his research and refused to reduce Friedman's patient load.
As good as Friedman was as a doctor, surgeon and researcher, he was actually a lousy cheater. One thing that brought about his demise, in fact, was that the initials he used for fictitious patients were the same as those of residents and faculty members in his program.
Friedman was repentant once caught, and he resigned from his positions at both Brigham and Women's, and Harvard.
May 6 to May 12 Those who follow the Chinese-language news may have noticed the usage of the term zhuge (豬哥, literally ‘pig brother,’ a male pig raised for breeding purposes) in reports concerning the ongoing #Metoo scandal in the entertainment industry. The term’s modern connotations can range from womanizer or lecher to sexual predator, but it once referred to an important rural trade. Until the 1970s, it was a common sight to see a breeder herding a single “zhuge” down a rustic path with a bamboo whip, often traveling large distances over rugged terrain to service local families. Not only
Ahead of incoming president William Lai’s (賴清德) inauguration on May 20 there appear to be signs that he is signaling to the Chinese Communist Party (CCP) and that the Chinese side is also signaling to the Taiwan side. This raises a lot of questions, including what is the CCP up to, who are they signaling to, what are they signaling, how with the various actors in Taiwan respond and where this could ultimately go. In the last column, published on May 2, we examined the curious case of Democratic Progressive Party (DPP) heavyweight Tseng Wen-tsan (鄭文燦) — currently vice premier
The last time Mrs Hsieh came to Cihu Park in Taoyuan was almost 50 years ago, on a school trip to the grave of Taiwan’s recently deceased dictator. Busloads of children were brought in to pay their respects to Chiang Kai-shek (蔣中正), known as Generalissimo, who had died at 87, after decades ruling Taiwan under brutal martial law. “There were a lot of buses, and there was a long queue,” Hsieh recalled. “It was a school rule. We had to bow, and then we went home.” Chiang’s body is still there, under guard in a mausoleum at the end of a path
Last week the Directorate-General of Budget, Accounting and Statistics (DGBAS) released a set of very strange numbers on Taiwan’s wealth distribution. Duly quoted in the Taipei Times, the report said that “The Gini coefficient for Taiwanese households… was 0.606 at the end of 2021, lower than Australia’s 0.611, the UK’s 0.620, Japan’s 0.678, France’s 0.676 and Germany’s 0.727, the agency said in a report.” The Gini coefficient is a measure of relative inequality, usually of wealth or income, though it can be used to evaluate other forms of inequality. However, for most nations it is a number from .25 to .50